Comparison of Sebia Free Light Chain Assay With Freelite Assay for the Clinical Management of Diagnosis, Response, and Relapse Assessment in Multiple Myeloma

Clinical Lymphoma, Myeloma & Leukemia
Helene CaillonThomas Dejoie

Abstract

Serum free light chain (FLC) measurement has become an important marker for the management of multiple myeloma (MM). However, several analytical challenges remain unresolved. We compared the clinical performances of the Sebia FLC assay in MM to the Freelite assay. A total of 177 patients from the IFM DFCI 2009 trial were enrolled onto this study, with a total of 368 samples analyzed. At baseline, concordance of the involved to noninvolved FLC ratio (iFLC/niFLC) was evaluated. During therapy, comparison of the disease response assessments according to International Myeloma Working Group criteria was performed. Compared to Freelite, the Sebia FLC assay demonstrated lower results, with a proportional bias with increased values. We demonstrated that the Sebia equivalent of the iFLC/niFLC ratio of 100 was 16. During follow-up, agreement in response assessment was moderate (for light chains MM) to good (for intact immunoglobulin MM). In the context of relapse, the concordance was moderate, but longitudinal follow-up showed a similar kinetics. The Sebia FLC assay provides inequivalent absolute results from the Freelite assay. Despite lower absolute FLC values, the kinetics of response and relapse is exactly the same. As with other FLC...Continue Reading

Citations

Nov 16, 2019·Clinical Chemistry and Laboratory Medicine : CCLM·Chérina K A FlemingHenk Russcher
Oct 16, 2019·Critical Reviews in Clinical Laboratory Sciences·Laura CaponiMaria Franzini
Mar 5, 2021·Clinical Biochemistry·Luis J Morales-García, María S Pacheco-Delgado
Jan 22, 2022·International Journal of Laboratory Hematology·Guoqing ZhuGang An

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Clinical Chemistry and Laboratory Medicine : CCLM
Pavai SthaneshwarGan Gin Gin
Clinical Chemistry and Laboratory Medicine : CCLM
Pierre-Yves BriandL Guenet
The Korean journal of laboratory medicine
Seonkyung JungWoo-Sung Min
Nihon rinsho. Japanese journal of clinical medicine
Shin-ichi Fuchida, Chihiro Shimazaki
© 2022 Meta ULC. All rights reserved